OSSTEC raises £2.5m led by Empirical Ventures to launch cementless knee implants.
Empirical Ventures led the financing for the Imperial College London spinout.
Share allotment filed at Companies House
An Imperial College London spinout developing cementless 3D-printed partial knee implants designed to encourage natural bone growth.
OSSTEC, a London-based medical technology startup, has secured £2.5m in funding led by Empirical Ventures. The capital will support the commercial launch of the company's cementless partial knee implants, which use 3D-printed structures to promote natural bone fixation and reduce failure rates in younger patients.
Founded in 2021 as a spinout from Imperial College London, OSSTEC builds upon a decade of underlying research. The firm's technology aims to address high revision rates associated with traditional cemented knee replacements by offering customisable implants that integrate with bone and robotic surgical systems.
The latest investment follows a seed round in March 2023 and brings total funding past £3m, bolstered by prior backing from various syndicates and innovation awards.
From the founder
"This funding marks a pivotal moment for OSSTEC, enabling us to bring our groundbreaking technology to market with our team of surgeons and engage in strategic collaborations to improve patient outcomes. We’re at the exciting intersection of innovative technology, delivering value for surgeons and patients and high-growth markets—all combined to help more people stay active and pain-free for longer. We’re excited to take the next steps in scaling our impact and making a meaningful difference in patients’ lives and the wider healthcare ecosystem."
Max Munford
CEO and Founder at OSSTEC
Investor perspective
"OSSTEC is an excellent example of how scientific discovery can be transformed into real-world impact. The company has huge potential to completely reform best practices in this field of healthcare, with an impressive team of scientists pushing the boundaries of engineering and medical research. In backing OSSTEC, we continue to drive forward Empirical Ventures’ own mission of empowering the next generation of innovators to turn their research into impactful solutions."
Johnathan Matlock
General Partner and Co-founder, Empirical Ventures
Use of funds
- 01Accelerate go-to-market